Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wunderink

Showing results (391-400 of 545) with videos related to

Pageof 55
Sort By:
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
Intensive Care Medicine|February 5, 2017
The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardshipMarin H Kollef, Matteo Bassetti, Bruno Francois, et al.
The Lancet. Infectious Diseases|May 14, 2023
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)Keith S Kaye, Andrew F Shorr, Richard G Wunderink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe OutcomesWesley H Self, Richard G Wunderink, Mark J DiNubile, et al.
Infection Control and Hospital Epidemiology|July 21, 2015
Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classificationScott T Micek, Marin H Kollef, Antoni Torres, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2007
Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumorsAlejandra Méndez Romero, Wouter Wunderink, Rob M van Os, et al.
Open Forum Infectious Diseases|July 22, 2017
Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community StudySara Tomczyk, Seema Jain, Anna M Bramley, et al.
Transplantation|July 27, 2018
Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant RecipientsHerman F Wunderink, Geert W Haasnoot, Caroline S de Brouwer, et al.
Bone Marrow Transplantation|May 20, 2023
Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosisLaura G M Daenen, Jan-Tom van der Bruggen, Roos J Leguit, et al.
Transplantation|July 24, 2019
HLA-B51 Reduces Risk of BK Polyomavirus Viremia After Kidney TransplantationHerman F Wunderink, Geert W Haasnoot, Caroline S de Brouwer, et al.
Pageof 55

Showing results (391-400 of 545) with videos related to

Sort By:
Pageof 55
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
Intensive Care Medicine|February 5, 2017
The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardshipMarin H Kollef, Matteo Bassetti, Bruno Francois, et al.
The Lancet. Infectious Diseases|May 14, 2023
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)Keith S Kaye, Andrew F Shorr, Richard G Wunderink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe OutcomesWesley H Self, Richard G Wunderink, Mark J DiNubile, et al.
Infection Control and Hospital Epidemiology|July 21, 2015
Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classificationScott T Micek, Marin H Kollef, Antoni Torres, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2007
Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumorsAlejandra Méndez Romero, Wouter Wunderink, Rob M van Os, et al.
Open Forum Infectious Diseases|July 22, 2017
Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community StudySara Tomczyk, Seema Jain, Anna M Bramley, et al.
Transplantation|July 27, 2018
Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant RecipientsHerman F Wunderink, Geert W Haasnoot, Caroline S de Brouwer, et al.
Bone Marrow Transplantation|May 20, 2023
Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosisLaura G M Daenen, Jan-Tom van der Bruggen, Roos J Leguit, et al.
Transplantation|July 24, 2019
HLA-B51 Reduces Risk of BK Polyomavirus Viremia After Kidney TransplantationHerman F Wunderink, Geert W Haasnoot, Caroline S de Brouwer, et al.
Pageof 55